Complexity of the Analytical Characterization of Polysorbate

Similar documents
Instability of Polysorbates in Protein Biopharmaceutics

Analytical strategies to monitor polysorbate in biotherapeutics. Christian Bell, Analytical Development, Roche March 2018

A New Look at Old Stuff. Molecular Heterogeneity of Polysorbates and Its Implications Studied with LC-MS.

Surfactants: Raw Material and Drug Product Control Strategy

Selecting Polysorbates:

Development and Validation of a Polysorbate 20 Assay in a Therapeutic Antibody Formulation by RP-HPLC and Charged Aerosol Detector (CAD)

Journal of Chemical and Pharmaceutical Research

ACQUITY UPLC WITH PDA DETECTION: DETERMINING THE SENSITIVITY LIMITS OF OXYBUTYNIN AND RELATED COMPOUNDS

Ultra Columns HPLC COLUMNS

Ultra Columns. also available. ordering note

Chromatogram Search Tool Search by compound name, synonym, CAS # or keyword Pinnacle II Columns

Impurity Profiling of Carbamazepine by HPLC/UV

vii LIST OF TABLES TABLE NO DESCRIPTION PAGE 1.1 System Suitability Parameters and Recommendations Acidic and Alkaline Hydrolysis 15

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

USP Excipient Stakeholder Forum, September 29 th 2016

CONTENT. i iv ix. SVKM s NMIMS, School of Pharmacy and Technology Management

A New HILIC/RP Mixed-Mode Column and Its Applications in Surfactant Analysis

SUCROSE OLIGOESTERS TYPE I

Stress Degradation Studies And Validation Method For Quantification Of Aprepitent In Formulations By Using RP-HPLC

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

World Journal of Pharmaceutical Research

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

Probing for Packaging Migrants in a Pharmaceutical Impurities Assay Using UHPLC with UV and Mass Detection INTRODUCTION

Colloid chemistry. Lecture 10: Surfactants

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

Application Note. Authors. Abstract. Petrochemical

Physical Pharmacy. Interfacial phenomena. Khalid T Maaroof MSc. Pharmaceutical sciences School of pharmacy Pharmaceutics department

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Removal of Triton X-100 from Plasma Samples Using Mixed-Mode Solid Phase Extraction (SPE)

Sanjog Ramdharane 1, Dr. Vinay Gaitonde 2

Solving practical problems. Maria Kuhtinskaja

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

3-MCPD esters in edible oils: analytical aspects

Polysorbate 80 Hydrolysis and Considerations for Control Strategy Development

Fast determination of residual glycerol and glycerides in biodiesel by SFC/MS using the Agilent 1260 Infinity Analytical SFC System

Product Guide for LudgerSep TM ur2 UHPLC Column for DMB Sialic Acid Analysis

HICHROM. Chromatography Columns and Supplies NEW PRODUCTS. Catalogue 9. Hichrom Limited

Product Guide for LudgerSep TM R1 HPLC Column for DMB labelled Sialic Acid Analysis

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

S. G. Talele, D. V. Derle. Department of Pharmaceutics, N.D.M.V.P. College of Pharmacy, Nashik, Maharashtra, India

Separation of Macrocyclic Lactones (Avermectins) on FLARE C18 MM & FLARE C18+ Columns

LOCALISATION, IDENTIFICATION AND SEPARATION OF MOLECULES. Gilles Frache Materials Characterization Day October 14 th 2016

[ APPLICATION NOTE ] The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns INTRODUCTION APPLICATION BENEFITS

Lipid Analysis. Andréina Laffargue, IRD CRYMCEPT Montpellier workshop, October 17th Introduction to lipid structures

Organic Chemistry Diversity of Carbon Compounds

The use of mass spectrometry in lipidomics. Outlines

Metabolomics: quantifying the phenotype

MICELLAR LIQUID CHROMATOGRAPHIC METHOD DEVELOPMENT FOR DETERMINATION OF 2,4,5,6-TETRAAMINO PYRIMIDINE SULPHATE SALT

USP Method Transfer of Ziprasidone HCl from HPLC to UPLC

Analysis of Food Sugars in Various Matrices Using UPLC with Refractive Index (RI) Detection

Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences

Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

High-Resolution Analysis of Intact Triglycerides by Reversed Phase HPLC Using the Agilent 1290 Infinity LC UHPLC System

Supplementary Fig. 1.

International Journal of Applied Pharmaceutical Sciences and Research

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

Pelagia Research Library

Tentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40

Pelagia Research Library

Analysis of Isoflavones with the PerkinElmer Flexar FX-15 UHPLC System Equipped with a PDA Detector

MULTIDIMENSIONALE SCHEIDINGEN IN DE GAS- EN VLOEISTOF CHROMATOGRAFIE

Pankti M. Shah et al, Asian Journal of Pharmaceutical Technology & Innovation, 04 (17); 2016; 07-16

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

Scholars Research Library. Der Pharmacia Lettre, 2016, 8 (6): (

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

Analysis of the fatty acids from Periploca sepium by GC-MS and GC-FID

Supplementary Information. Effects of Perfluorooctanoic Acid on Metabolic Profiles in Brain and Liver of Mouse by a

T U R B I S C A N. Automatic stability analyses for pharmaceutics

4 Development of an ESR online-method for the monitoring of in vitro fat digestion

SPE Cartridges. All Finneran Products Are Certified. Conditioning Sample application Wash Elution

Analysis of HMF by HPLC

ANALYTICAL TECHNIQUES FOR THE QUALITY OF ANTI- AIDS DRUGS

SMART Digest Kit Facilitating perfect digestion

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

Available online at Scholars Research Library

Development and Validation of Stability Indicating HPTLC Method for Estimation of Seratrodast

HPLC to UHPLC Transfer of USP Method for Amlodipine Besylate Using the Agilent 1290 Infinity II LC

Bioanalytical Quantitation of Biotherapeutics Using Intact Protein vs. Proteolytic Peptides by LC-HR/AM on a Q Exactive MS

Supporting information

Selectivity Comparison of Agilent Poroshell 120 Phases in the Separation of Butter Antioxidants

ESTIMATION OF OXOLAMINE PHOSPHATE INDICATING HPLC METHOD: METHOD DEVELOPMENT AND VALIDATION

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

A Stability Indicating HPLC Method for the Determination of Fluvoxamine in Pharmaceutical Dosage Forms

3.1.3 Lipids. Source: AQA Spec

Simultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by RP-HPLC method

Rapid and Direct Analysis of Free Phytosterols by Reversed Phase HPLC with Electrochemical Detection

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Marc Plante, Bruce Bailey, and Ian N. Acworth Thermo Fisher Scientific, Chelmsford, MA, USA

Lipid oxidation and related protein modifications in oil-in-water emulsions

LC/MS Analysis of Various Hydrophilic Compounds Using a Polymer-Based Amino Column - Shodex TM HILICpak TM VG-50 2D

Pharmaceutica Analytica Acta

Relative Measurement of Zeaxanthin Stereoisomers by Chiral HPLC

Barry Boyes 1,2, Shujuan Tao 2, and Ron Orlando 2

AOAC Research Institute Performance Tested Methods SM Program. Measurement of Free Fatty Acids Using FASafe Standard Test Kit. Certificate Report

Analysis of Common Sweeteners and Additives in Beverages with the PerkinElmer Flexar FX-15 System Equipped with a PDA Detector

Zillillah, a Guowei Tan, a,b and Zhi Li* a,b. 4 Engineering Drive 4, Singapore Fax: ; Tel:

Transcription:

Complexity of the Analytical Characterization of Polysorbate Case Studies for Degradation Profiling CASSS AT Europe 2018 in Barcelona, 07 Mar 2018 K. Wuchner, Janssen R&D, Schaffhausen, Switzerland W. Koch, E. Corradini, A. Hawe, Coriolis Pharma, München, Germany DISCLAIMER The perspectives and opinions in this talk are those of the presenter.

Functional role of Polysorbates (PS) in biopharmaceutical formulations Polysorbate 20 and 80 are the most common non-ionic surfactants in biopharmaceutical products PS have a high surface activity at low concentration and are used as excipient to: Prevent protein adsorption Protect protein against interfacial stress, surface-induced aggregation and particle formation Concentration range in protein therapeutics from 0.001 to 0.1% (w/v) [PS] optimum is experimentally determined by stability studies and stress-studies Depends on the stabilization mechanism (competition/ protein-ps interaction) Formation of side/degradation products (e.g., PS related particles) Analytical assessment of polysorbate composition, purity and stability are important during drug product development to ensure sufficient stabilization while minimizing negative side-effects of PS 1

Compendial Grade PS Idealized structure of PS20 y+y+z = 20 Idealized structure of PS80 y+y+z = 20 Martos et al. (2017), J Pharm Sci, 106:1722-1735 EP, USP and JP have harmonized requirements for PS80, which is composed of multiple fatty acid (FA) esters (PS20: JP is not harmonized) China enforces compliance to the ChP 2015 and requires all oleic acid ( 98.0%) Grade PS80 2

Complexity of Multi-compendial PS Idealized structure of PS20 y+y+z = 20 Optimized UPLC-MS separation of PS20 shows complex chromatogram with approximately 4000 peaks based on MS spectra (parent (adduct) ions are counted as one peak) 3

Complexity of Multi-compendial PS Sharp peak 4

Complexity of Multi-compendial PS The sharp peak at 25.7 min is composed by at least ~ 10 peaks based on mass data Isosorbitane-PEGx10-mono-laurate with different PEG-ylation levels High Resolution MS is needed to cope with heterogeneous composition of PS 5

Degradation increases complexity Native Polysorbate Potential isomeric forms of sorbitan core Various poly(oxyethylene) chains (PEGs) Different fatty acids (FA) esterified Mono, di-, tri-, tetra-esters Impurities/byproducts Peroxides Free FAs, PEGs.. Hydrolysis (chemical, enzymatic) Mono-, di, tri-esters Free FAs (FFAs) Free PEGs Oxidation Free FAs, free PEGs.. Peroxides Oxidized FAs, PEGs (intermediates) Short chain organic acids, aldehydes, ketones PS degradation leads to Loss of PS surfactant functionality and loss of solubilization capacity Protein aggregation/precipitation Protein oxidation Generation of hydrophobic PS degradants (e.g., FFAs) Formation of particles composed of PS degradants 6

Challenges for analytical characterization of PS Polysorbate heterogeneity complex mixture, markers for degradation pathway are difficult to identify (needle in haystack) (reactive) degradants: transient nature and difficult to isolate no universal PS standard available as reference (e.g. for calibration curves) Lack of chromophores derivatization or universal detectors (CAD, ELSD, MS) required Interference of protein and excipients with the analytical methods sample work-up required (in particular protein removal) 7

Analytical methods for PS in biopharmaceutical formulations PS content (validated method with acceptance criteria, R/S) Fluorescent micelle assay (e.g. NPN assay) Liquid Chromatography (LC) with charged aerosol detector (CAD) or evaporative light scattering detector (ELSD) PS subclass analysis (characterization method, fast, quantitative) HPLC-CAD or ELSD incl. sample preparation for selective isolation of PS PS degradants in protein-formulations (characterization method, MS for identification) UPLC- MS (positive and/or negative mode) incl. sample preparation for selective isolation of PS; FA specific methods Other methods Particle characterization methods to determine composition/nature Peroxide assays, ICP-MS, excipient related methods 8

PS content in biopharmaceutical formulations Method based on the fluorescent dye N-phenyl-1- napthylamine (NPN) Fluorescence assay can be used to determine PS content in aqueous solutions No sample preparation (just dilution), automated method (use of well plates) NPN [PS] CMC: NPN in hydrophobic micellar interior -> high quantum yield Good linearity Caveats of the NPN assay: NPN interacts with hydrophobic compounds interference by certain proteins and silicone oil NPN assay is not suitable to quantify PS in each biopharmaceutical formulation 9

PS content and PS class determinations in biopharmaceutical formulations Fast LC-CAD method to monitor major components of PS LC-CAD chromatogram for PS20 PS can be determined in aqueous solutions (without sample preparation) Protein needs to be removed e.g., by off-line SPE for biopharmaceutical formulations Short cycle times of 15 min Range: 60 1000 µg/ml (~0.006 0.1% w/v) PS 10

Enzymatic degradation studies LC-CAD method to monitor esterase (0.005 U/mL) induced degradation of 0.04% PS formulated at ph 6 Mono-ester species degrade faster than Poly-esters Free PEG fractions increase concomitantly Part of poly-esters degrades in PS20 but not in PS80 (no change) No significant difference between Chinese and multicompendial grade PS80 LC-CAD with high sample throughput enabled monitoring of PS degradation at multiple time points to get insight into kinetics 11

Characterization of PS related molecules and degradants in biopharmaceutical formulations Off-line SPE Isolate PS constituents from Protein/other excipients based on hydrophobicity UPLC-HRMS method Positive Mode: Sensitive detection of PS related molecules PS degradation pattern of esters Negative Mode: Sensitive detection of FFAs and related oxidized degradants protein polysorbate 12

Example for multicompendial and Chinese grade PS80 by UPLC-HRMS (pos mode) Differences in overall pattern (base peak chromatogram) is less pronounced as would be expected based on the ChP requirement for oleic acid only grade ( 98%) 13

Oxidative degradation studies (Fe(II)SO 4 ) UPLC-HRMS (pos mode) method to monitor oxidative degradation of 0.04% PS formulated at ph 6 PS80 USP vs PS80 ChP after 4 days at 40 C (Fe(II) sulfate) Chinese grade PS80 shows after 4 days exposure complete loss of polyester and monoester fractions Chinese grade PS80 also with higher levels of oxidative degradants compared to multi-compendial PS80 14

Oxidative degradation studies (Fe(II)SO 4 ) UPLC-HRMS (pos mode) method to monitor oxidative degradation of 0.04% PS formulated at ph 6 at 25 C Oxidized ester PS degradant 1 Chinese grade PS80 show a shorter lag-phase for the formation and higher levels of oxidized degradants compared to multi-compendial grade PS20 shows lower levels compared to PS80 for intermittent oxidized ester PS degradant 15

Oxidative degradation studies (Fe(II)SO 4 ) UPLC-HRMS (neg mode) method to monitor oxidative degradation of 0.04% PS formulated at ph 6 at 25 C Oxidized FA PS degradant 2 Koch et al. (2018), manuscript under preparation. Some oxidized products are intermittent, others do not decompose during monitored time period Free ( soluble ) oleic acid was not detected at high levels (either only present in oxidized forms or as FA in mixed micelles or as emulsion at 25 C) 16

Number of particles/ml Characterization of insoluble fraction of PS Biopharmaceutical product stressed at 40 C 700.0 Subvisible particle analysis by light-obscuration 600.0 500.0 400.0 Examples of MFI images 300.0 200.0 100.0 0.0 0 1 2 3 4 5 6 7 Expsoure time in months 10µm particles/ml 25µm particles/ml Increase in subvisible particles after lag-time Smaller ( 10µm) particles increase first, then larger ( 25µm) particles Morphology of PS related particles is variable and not always easily distinguishable from proteinaceous particles 17

Characterization of PS related (subvisible) particles Isolation of particles on filter for advanced characterization of their nature and composition by FTIR- microscopy and SEM-EDX SEM image on filter surface FTIR Spectra: Fatty acid related nature EDX Spectra: C, O major elements, trace metals (Au from filter surface) 18

PS Analytical Toolbox with Complementary Assays Quantitative methods to assess number and size of particles Advanced characterization methods to determine nature and composition Easy, fast, quantitative PS assay for surface active fraction of PS Particle characterization tools PS content PS class analysis Fast quantitative assay for major PS constituents with efficient removal of protein (if possible automated) Quantitative methods to assess degradation of excipients (e.g., oxidation of histidine) or stabilizers (e.g., Met) ICP-MS for metal (drivers for oxidative stress) Excipient assay UPLC-HRMS PS characterization assay Optimized LC-MS assay with sample preparation to eliminate protein interferences and advanced data analysis tools for efficient read-out of complex PS mixture Reliable, automated assay to assess peroxides (incl. lipid species) in protein formulations to evaluate drivers and kinetics of oxidants in DP Oxidant assay Fatty acid assay Quantitative assay for free fatty acids in protein formulations to assess risk of particle formation 19

Janssen R&D, Pharmaceutical Development & Manufacturing Sciences René Spycher Jochen Büchler Mehul Patel Coriolis Pharma Michelle Berger Constanze Helbig Ariadna Martos Acknowledgments 20